Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Solventum Corporation Common Stock
(NY:
SOLV
)
85.17
+0.42 (+0.49%)
Delayed Quote
Updated: 2:47 PM EST, Nov 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Solventum Corporation Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
2 cash-burning stocks for long-term investors and 1 we turn down
October 23, 2026
While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sh...
Via
StockStory
Topics
Credit Cards
3 Overrated Stocks We Approach with Caution
October 02, 2026
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab...
Via
StockStory
Surgical Equipment & Consumables - Diversified Stocks Q2 Recap: Benchmarking CONMED (NYSE:CNMD)
October 01, 2026
Looking back on surgical equipment & consumables - diversified stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including CONMED (NY...
Via
StockStory
Topics
Artificial Intelligence
Economy
2 Profitable Stocks for Long-Term Investors and 1 We Question
September 29, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via
StockStory
Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds
↗
September 23, 2026
Via
Chartmill
Due Diligence Check: Do These "Blue Chips" Still Earn the Title?
↗
September 23, 2026
"Blue chip" gets applied to a company once and tends to stick, regardless of what the balance sheet does afterward. The label describes reputation, not cur
Via
Talk Markets
Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses
September 15, 2026
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking a...
Via
StockStory
Topics
Artificial Intelligence
Economy
3 S&P 500 Stocks with Open Questions
September 09, 2026
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
Via
StockStory
Topics
Stocks
2 Mid-Cap Stocks to Consider Right Now and 1 That Underwhelm
August 31, 2026
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...
Via
StockStory
Topics
Energy
3 Value Stocks with Open Questions
August 28, 2026
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
Via
StockStory
3 Reasons to Avoid SOLV and 1 Stock to Buy Instead
August 28, 2026
Solventum’s 22% return over the past six months has outpaced the S&P 500 by 10.4%, and its stock price has climbed to $89.05 per share. This was partly due t...
Via
StockStory
Topics
Stocks
1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges
August 20, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...
Via
StockStory
Solventum (SOLV) Q2 2026 Earnings Call Transcript
↗
August 12, 2026
CEO Hanson discusses HIS separation strategy and $2.2B in quarterly sales growth.
Via
The Motley Fool
Topics
Earnings
World Trade
Q2 Rundown: STERIS (NYSE:STE) Vs Other Surgical Equipment & Consumables - Diversified Stocks
August 11, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how surgical equipment & c...
Via
StockStory
Topics
Artificial Intelligence
Economy
Solventum Q2 Earnings Call Highlights
↗
August 09, 2026
Solventum (NYSE:SOLV) reported second-quarter results that exceeded its internal expectations, supported by broad-based segment performance, planned order activity ahead of an ERP cutover and a tariff...
Via
MarketBeat
Topics
ETFs
Earnings
World Trade
SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook
August 07, 2026
Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 2.2% year on year to $2....
Via
StockStory
Solventum Nears Inflection Point As It Begins to Unlock Value
↗
August 07, 2026
Solventum shares gain on strong Q2 revenue, earnings, and cash flow, buybacks, and improved guidance, with analysts raising price targets amid a discounted valuation versus med/tech peers.
Via
MarketBeat
Topics
Initial Public Offering
Explore the top gainers and losers within the S&P500 index in today's session.
↗
August 06, 2026
Via
Chartmill
Solventum (NYSE:SOLV) Posts Better-Than-Expected Sales In Q2 CY2026
August 05, 2026
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 2.2% year on year to ...
Via
StockStory
Stay updated with the S&P500 stocks that are on the move in today's after-hours session.
↗
August 05, 2026
Via
Chartmill
What To Expect From Solventum’s (SOLV) Q2 Earnings
August 03, 2026
Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting results this Wednesday after market hours. Here’s what you need to know. Solventum beat...
Via
StockStory
3 Hyped Up Stocks That Fall Short
July 31, 2026
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements...
Via
StockStory
Exploring the top movers within the S&P500 index during today's session.
↗
July 28, 2026
Via
Chartmill
Tuesday's session: top gainers and losers in the S&P500 index
↗
July 28, 2026
Via
Chartmill
These S&P500 stocks are gapping in today's session
↗
July 28, 2026
Via
Chartmill
3 Reasons SOLV is Risky and 1 Stock to Buy Instead
July 24, 2026
Since January 2026, Solventum has been in a holding pattern, posting a small loss of 2.2% while floating around $77.29. The stock also fell short of the S&P ...
Via
StockStory
Topics
Stocks
2 S&P 500 Stocks to Own for Decades and 1 We Question
July 07, 2026
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
Via
StockStory
Topics
Stocks
3 Mid-Cap Stocks We Steer Clear Of
June 29, 2026
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...
Via
StockStory
3 Healthcare Stocks with Questionable Fundamentals
June 25, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have realiz...
Via
StockStory
What's going on in today's pre-market session: S&P500 movers
↗
June 22, 2026
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
